Day: November 6, 2023

The phase II study led by Dr. Kenneth Cusi evaluating lanifibranor in patients with T2D and MASLD was selected as late breaker. Two additional scientific abstracts from the NATIVE Phase IIb clinical trial evaluating lanifibranor for the treatment of patients with NASH have been selected  for presentation. The two abstracts show:the correlation between the increase of adiponectin under lanifibranor and the improvement of histological and serum markers of NASH severity both in terms of activity and fibrosis. the improvement of liver histology and markers of cardiometabolic health in patients with NASH treated with lanifibranor, independent of PNPLA3 genotype.Daix (France), Long Island City (New York, United States), November 6, 2023 – Inventiva (Euronext Paris and Nasdaq: IVA) (the “Company”), a clinical-stage biopharmaceutical company...

ROUND ROCK, Texas, Nov. 06, 2023 (GLOBE NEWSWIRE) — TSS, Inc. (Other OTC: TSSI), a data center and mission critical facilities and technology services company, will report financial results for its third quarter 2023 on Monday November 13th, 2023. The Company will conduct a conference call at 4.30 p.m. eastern time that day. To participate on the conference call, please dial 1-888-596-4144 toll free from the U.S., or 1-646-968-2525 for international callers. The event ID number is 3667493. Investors may also access a live audio web cast of this conference call under the “events” tab on the investor relations section of the Company’s website at https://tss-inc.ir.rdgfilings.com . An audio replay of the conference call will be available approximately four hours after the conclusion of the call and will be made available until...

GOLDEN, Colo., Nov. 06, 2023 (GLOBE NEWSWIRE) — Truleum, Inc. (OTC.PK – TRLM) (“Truleum”) announced today that it has acquired quitclaim title to various tracts of the Logan Project covering approximately 400 additional acres. Ownership of the additional acres has now been clarified adding the approximate 400 acres covering nine (9) well bores owned and operated by Truleum. The company’s acreage held in the Project increased from 1380 to 1620 net acres. The new acreage adds behind-pipe potential in some of the nine affected wellbores and adds full interest in undrilled locations that Truleum can now access with clear title. The Company’s current reserve report dated October 16, 2023 was prepared by an independent petroleum engineering firm (“Liquid Gold Technologies”) prior to the acquisition of the additional acres. It is available...

OTTAWA, Nov. 06, 2023 (GLOBE NEWSWIRE) — Calian Group Ltd. (TSX: CGY), a diverse products and services company providing innovative healthcare, communications, learning and cybersecurity solutions is proud to announce the appointment of Michael Tremblay as President, IT and Cyber Solutions (ITCS). Mike joined Invest Ottawa & Bayview Yards as President and CEO in March of 2017. Recently, Mike was appointed a World Economic Forum Fellow as part of the Centre for Urban Transformation and Invest Ottawa’s leadership work at AREA X.O, Canada’s mobility Futureplex of innovation and collaboration. With 38 years of sales, marketing, operations, general management experience, coupled with considerable knowledge of public sector clients, Mike has held senior executive positions with Microsoft, SAP, Fujitsu Consulting, JDS Uniphase, EDS...